Merck to Buy Terns for $6.7B to Grow in Blood Cancers
Bloomberg’s Michelle Davis joins Dani Burger on “Bloomberg Deals.” Merck agreed to buy Terns Pharmaceuticals for $6.7 billion, giving the…
Bloomberg’s Michelle Davis joins Dani Burger on “Bloomberg Deals.” Merck agreed to buy Terns Pharmaceuticals for $6.7 billion, giving the…
Pharma giant Merck is buying U.S. biotech firm Terns Pharmaceuticals for $6.7 billion, the company said Wednesday. This is the…
Terns Pharmaceuticals Inc. (NASDAQ:TERN) is one of 15 stocks with the biggest hedge fund momentum, after gaining 42 hedge fund…
Urban e-bike maker Tern just hit a major milestone in one of the toughest proving grounds on the planet: New…